{"id":"https://openalex.org/W4389763564","doi":"https://doi.org/10.1515/dmpt-2023-0079","title":"Pharmacogenetic aspects of efficacy and safety of methotrexate treatment in pediatric acute lymphoblastic leukemia","display_name":"Pharmacogenetic aspects of efficacy and safety of methotrexate treatment in pediatric acute lymphoblastic leukemia","publication_year":2023,"publication_date":"2023-12-01","ids":{"openalex":"https://openalex.org/W4389763564","doi":"https://doi.org/10.1515/dmpt-2023-0079","pmid":"https://pubmed.ncbi.nlm.nih.gov/38098143"},"language":"en","primary_location":{"id":"doi:10.1515/dmpt-2023-0079","doi":"https://doi.org/10.1515/dmpt-2023-0079","is_oa":false,"landing_page_url":"https://doi.org/10.1515/dmpt-2023-0079","pdf_url":null,"source":{"id":"https://openalex.org/S4210201967","display_name":"Drug Metabolism and Personalized Therapy","issn_l":"2363-8907","issn":["2363-8907","2363-8915"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310313990","host_organization_name":"De Gruyter","host_organization_lineage":["https://openalex.org/P4310313990"],"host_organization_lineage_names":["De Gruyter"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Metabolism and Personalized Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076501105","display_name":"\u041e. D. Gurieva","orcid":"https://orcid.org/0000-0002-0050-0721","observed_orcids":["https://orcid.org/0000-0002-0050-0721"]},"institutions":[{"id":"https://openalex.org/I4210090957","display_name":"Russian Cancer Research Center NN Blokhin","ror":"https://ror.org/00ab9fg88","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210090957"]},{"id":"https://openalex.org/I4210117042","display_name":"Ministry of Health of the Russian Federation","ror":"https://ror.org/01p8ehb87","country_code":"RU","type":"government","lineage":["https://openalex.org/I4210117042"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Oksana Dmitryevna Gurieva","raw_affiliation_strings":["Department of Pediatric Oncology and Hematology Research Institute , N.N. Blokhin National Medical Research Cancer Center of the Ministry of Health of Russia , Moscow , Russia"],"raw_orcid":"https://orcid.org/0000-0002-0050-0721","affiliations":[{"raw_affiliation_string":"Department of Pediatric Oncology and Hematology Research Institute , N.N. Blokhin National Medical Research Cancer Center of the Ministry of Health of Russia , Moscow , Russia","institution_ids":["https://openalex.org/I4210090957","https://openalex.org/I4210117042"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057437704","display_name":"Marina Ivanovna Savelyeva","orcid":"https://orcid.org/0000-0002-2373-2250","observed_orcids":["https://orcid.org/0000-0002-2373-2250"]},"institutions":[{"id":"https://openalex.org/I23236222","display_name":"Yaroslavl State Medical Academy","ror":"https://ror.org/00ctbs693","country_code":"RU","type":"education","lineage":["https://openalex.org/I23236222"]}],"countries":["RU"],"is_corresponding":true,"raw_author_name":"Marina Ivanovna Savelyeva","raw_affiliation_strings":["Department of Therapy , Institute of Continuous Professional Education, Yaroslavl State Medical University of the Ministry of Health of Russia , Yaroslavl , Russia"],"raw_orcid":"https://orcid.org/0000-0002-2373-2250","affiliations":[{"raw_affiliation_string":"Department of Therapy , Institute of Continuous Professional Education, Yaroslavl State Medical University of the Ministry of Health of Russia , Yaroslavl , Russia","institution_ids":["https://openalex.org/I23236222"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018288705","display_name":"Timur Teimurazovich Valiev","orcid":"https://orcid.org/0000-0002-1469-2365","observed_orcids":["https://orcid.org/0000-0002-1469-2365"]},"institutions":[{"id":"https://openalex.org/I17877952","display_name":"Sechenov University","ror":"https://ror.org/02yqqv993","country_code":"RU","type":"education","lineage":["https://openalex.org/I17877952"]},{"id":"https://openalex.org/I4210090957","display_name":"Russian Cancer Research Center NN Blokhin","ror":"https://ror.org/00ab9fg88","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210090957"]},{"id":"https://openalex.org/I4210117042","display_name":"Ministry of Health of the Russian Federation","ror":"https://ror.org/01p8ehb87","country_code":"RU","type":"government","lineage":["https://openalex.org/I4210117042"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Timur Tejmurazovich Valiev","raw_affiliation_strings":["Department of Oncology , I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russia , Moscow , Russia","Department of Pediatric Oncology and Hematology Research Institute , N.N. Blokhin National Medical Research Cancer Center of the Ministry of Health of Russia , Moscow , Russia"],"raw_orcid":"https://orcid.org/0000-0002-1469-2365","affiliations":[{"raw_affiliation_string":"Department of Oncology , I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russia , Moscow , Russia","institution_ids":["https://openalex.org/I17877952"]},{"raw_affiliation_string":"Department of Pediatric Oncology and Hematology Research Institute , N.N. Blokhin National Medical Research Cancer Center of the Ministry of Health of Russia , Moscow , Russia","institution_ids":["https://openalex.org/I4210090957","https://openalex.org/I4210117042"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021716065","display_name":"Zhannet Alimovna Sozaeva","orcid":"https://orcid.org/0000-0001-5166-7903","observed_orcids":["https://orcid.org/0000-0001-5166-7903"]},"institutions":[{"id":"https://openalex.org/I4210108300","display_name":"Russian Medical Academy of Continuous Professional Education","ror":"https://ror.org/01t6bjk79","country_code":"RU","type":"education","lineage":["https://openalex.org/I4210108300","https://openalex.org/I4210117042"]},{"id":"https://openalex.org/I4210117042","display_name":"Ministry of Health of the Russian Federation","ror":"https://ror.org/01p8ehb87","country_code":"RU","type":"government","lineage":["https://openalex.org/I4210117042"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Zhannet Alimovna Sozaeva","raw_affiliation_strings":["Research Institute of Molecular and Personalized Medicine, Russian Medical Academy of Continuous Professional Education of the Ministry of Health of Russia , Moscow , Russia"],"raw_orcid":"https://orcid.org/0000-0001-5166-7903","affiliations":[{"raw_affiliation_string":"Research Institute of Molecular and Personalized Medicine, Russian Medical Academy of Continuous Professional Education of the Ministry of Health of Russia , Moscow , Russia","institution_ids":["https://openalex.org/I4210108300","https://openalex.org/I4210117042"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031964113","display_name":"Svetlana Nikolaevna Kondratenko","orcid":"https://orcid.org/0000-0003-1323-7894","observed_orcids":["https://orcid.org/0000-0003-1323-7894"]},"institutions":[{"id":"https://openalex.org/I17877952","display_name":"Sechenov University","ror":"https://ror.org/02yqqv993","country_code":"RU","type":"education","lineage":["https://openalex.org/I17877952"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Svetlana Nikolaevna Kondratenko","raw_affiliation_strings":["Department of Clinical Pharmacology and Propaedeutics of Internal Diseases , I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russia , Moscow , Russia"],"raw_orcid":"https://orcid.org/0000-0003-1323-7894","affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology and Propaedeutics of Internal Diseases , I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russia , Moscow , Russia","institution_ids":["https://openalex.org/I17877952"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5051165361","display_name":"Mikhail Vitalyevich Ilyin","orcid":"https://orcid.org/0000-0001-6278-374X","observed_orcids":["https://orcid.org/0000-0001-6278-374X"]},"institutions":[{"id":"https://openalex.org/I23236222","display_name":"Yaroslavl State Medical Academy","ror":"https://ror.org/00ctbs693","country_code":"RU","type":"education","lineage":["https://openalex.org/I23236222"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Mikhail Vitalyevich Ilyin","raw_affiliation_strings":["Department of Therapy, Institute of Continuous Professional Education, Yaroslavl State Medical University of the Ministry of Health of Russia , Yaroslavl , Russia"],"raw_orcid":"https://orcid.org/0000-0001-6278-374X","affiliations":[{"raw_affiliation_string":"Department of Therapy, Institute of Continuous Professional Education, Yaroslavl State Medical University of the Ministry of Health of Russia , Yaroslavl , Russia","institution_ids":["https://openalex.org/I23236222"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5057437704"],"corresponding_institution_ids":["https://openalex.org/I23236222"],"apc_list":{"value":2000,"currency":"EUR","value_usd":2163},"apc_paid":null,"fwci":1.3484,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.80132149,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":97},"biblio":{"volume":"38","issue":"4","first_page":"349","last_page":"357"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.5853999853134155,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.5853999853134155,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.32670000195503235,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.060100000351667404,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.972000002861023},{"id":"https://openalex.org/keywords/childhood-acute-lymphoblastic-leukemia","display_name":"childhood acute lymphoblastic leukemia","score":0.9729999899864197},{"id":"https://openalex.org/keywords/pharmacogenetics","display_name":"pharmacogenetics","score":0.9670000076293945},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.8090000152587891},{"id":"https://openalex.org/keywords/slco1b1","display_name":"SLCO1B1","score":0.9390000104904175},{"id":"https://openalex.org/keywords/genetic-polymorphism","display_name":"genetic polymorphism","score":0.8859999775886536},{"id":"https://openalex.org/keywords/methotrexate-toxicity","display_name":"methotrexate toxicity","score":0.8679999709129333},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.7850000262260437},{"id":"https://openalex.org/keywords/drug-transporters","display_name":"drug transporters","score":0.652999997138977},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.578000009059906},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.39899998903274536},{"id":"https://openalex.org/keywords/personalized-treatment","display_name":"personalized treatment","score":0.7269999980926514}],"concepts":[{"id":"https://openalex.org/C55775858","wikidata":"https://www.wikidata.org/wiki/Q1152227","display_name":"Pharmacogenetics","level":4,"score":0.7624337673187256},{"id":"https://openalex.org/C2776598434","wikidata":"https://www.wikidata.org/wiki/Q18035517","display_name":"SLCO1B1","level":5,"score":0.7565625905990601},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6794676780700684},{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.6712148785591125},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.582709014415741},{"id":"https://openalex.org/C2777793932","wikidata":"https://www.wikidata.org/wiki/Q1116229","display_name":"Common Terminology Criteria for Adverse Events","level":3,"score":0.5716197490692139},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.537763774394989},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4040731191635132},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3986736834049225},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.3167138397693634},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.19992753863334656},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.12108302116394043},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.07769399881362915}],"mesh":[{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005838","descriptor_name":"Genotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D010597","descriptor_name":"Pharmacogenetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020641","descriptor_name":"Polymorphism, Single Nucleotide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D027381","descriptor_name":"Liver-Specific Organic Anion Transporter 1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D054198","descriptor_name":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D054198","descriptor_name":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1515/dmpt-2023-0079","doi":"https://doi.org/10.1515/dmpt-2023-0079","is_oa":false,"landing_page_url":"https://doi.org/10.1515/dmpt-2023-0079","pdf_url":null,"source":{"id":"https://openalex.org/S4210201967","display_name":"Drug Metabolism and Personalized Therapy","issn_l":"2363-8907","issn":["2363-8907","2363-8915"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310313990","host_organization_name":"De Gruyter","host_organization_lineage":["https://openalex.org/P4310313990"],"host_organization_lineage_names":["De Gruyter"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Metabolism and Personalized Therapy","raw_type":"journal-article"},{"id":"pmid:38098143","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38098143","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug metabolism and personalized therapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W1492120359","https://openalex.org/W1656539109","https://openalex.org/W1975903555","https://openalex.org/W1983888778","https://openalex.org/W1992966943","https://openalex.org/W2005615400","https://openalex.org/W2011669229","https://openalex.org/W2053625082","https://openalex.org/W2055940669","https://openalex.org/W2066651895","https://openalex.org/W2079675818","https://openalex.org/W2108339680","https://openalex.org/W2114340167","https://openalex.org/W2126292029","https://openalex.org/W2126864090","https://openalex.org/W2129471193","https://openalex.org/W2493103431","https://openalex.org/W2613180806","https://openalex.org/W2725970815","https://openalex.org/W2734983688","https://openalex.org/W2778468835","https://openalex.org/W2915429197","https://openalex.org/W3034470028","https://openalex.org/W3038415010","https://openalex.org/W3099081347","https://openalex.org/W3143506887","https://openalex.org/W3206771726","https://openalex.org/W4301392858"],"related_works":["https://openalex.org/W4384696388","https://openalex.org/W1991552974","https://openalex.org/W4415762431","https://openalex.org/W4200579554","https://openalex.org/W2016058563","https://openalex.org/W2474812739","https://openalex.org/W6943533777","https://openalex.org/W2974677450","https://openalex.org/W2063725536","https://openalex.org/W3034470028"],"abstract_inverted_index":{"OBJECTIVES:":[0],"To":[1],"evaluate":[2],"the":[3,18,28,53,96,99,115,134,137,141,155],"role":[4],"of":[5,20,23,30,72,95,101,117,136,144,170],"ABCB1":[6,73],"(C3435T":[7],"rs1045642,":[8],"rs1128503,":[9],"rs2032582,":[10],"rs4148738),":[11],"SLCO1B1":[12,75],"T521C":[13],"rs4149056":[14],"genetic":[15,127],"polymorphisms":[16,71,128],"in":[17,36],"development":[19,116],"major":[21],"types":[22],"methotrexate":[24,120],"(MTX)":[25],"toxicities":[26],"and":[27,47,74,106,150],"occurrence":[29],"a":[31],"terminal":[32,151],"event":[33],"(death,":[34],"relapse)":[35],"pediatric":[37,159],"\u0410LL.":[38],"METHODS:":[39],")":[40],"methotrexate.":[41],"MTX-related":[42],"toxicities,":[43],"including":[44],"hematologic,":[45],"hepatic":[46],"renal,":[48],"were":[49],"evaluated":[50],"according":[51],"to":[52,69,119],"common":[54],"terminology":[55],"criteria":[56,157],"for":[57,158],"adverse":[58],"events":[59],"version":[60],"5.0":[61],"(CTCAE":[62],"v.5.0).":[63],"Real-time":[64],"PCR":[65],"method":[66],"was":[67,80],"used":[68],"investigate":[70],"genes.":[76],"The":[77,93,130],"study":[78,97],"material":[79],"peripheral":[81],"blood.":[82],"RESULTS:":[83],"A":[84],"competitive":[85],"analysis":[86,111],"demonstrated":[87],"significant":[88],"relationships":[89,102],"between":[90,103],"MTX":[91,107,147],"ADRs.":[92],"results":[94,132],"support":[98],"existence":[100],"some":[104],"ADRs":[105,149],"kinetics.":[108],"An":[109],"associative":[110],"showed":[112],"association":[113],"with":[114,140,163],"AEs":[118],"indicating":[121],"their":[122],"clinical":[123],"significance":[124],"from":[125],"different":[126],"protein-transporters.":[129],"available":[131],"confirm":[133],"associations":[135],"studied":[138],"genes":[139],"increased":[142],"risk":[143,161],"high":[145],"doses":[146],"toxic":[148],"events.":[152],"CONCLUSIONS:":[153],"Complementing":[154],"existing":[156],"ALL":[160],"groups":[162],"pharmacogenetic":[164],"indicators":[165],"will":[166],"allow":[167],"further":[168],"individualization":[169],"therapy.":[171]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2023,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2023-12-15T00:00:00"}